IDiyas

For the Inventor, By the Inventor

Lincoln Park, NJ, United States of America

Piotr Henryk Karpinski

USPTO Granted Patents = 23 


 

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 112(Granted Patents)


Location History:

  • Lincoln Park, MA (US) (2016 - 2017)
  • East Hanover, NJ (US) (2016 - 2019)
  • Lincoln Park, NJ (US) (2011 - 2023)

Company Filing History:

goldMedal20 out of 3,923 
 
Novartis Ag
 patents
silverMedal3 out of 19 
 
Novartis Pharmaceuticals Corporation
 patents
bronzeMedal1 out of 8 
 
Novartis Pharma Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2011-2023

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):
1. 11642329 - Amorphous solid form of compounds containing S—N-valeryl-N- {[2'-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations (2023-05-09),
2. 11096918 - Amorphous solid form of compounds containing S—N-valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations (2021-08-24),
3. 10421755 - Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors (2019-09-24),
4. 9802931 - Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors (2017-10-31),
5. 9624192 - Carbamate/urea derivatives (2017-04-18),
6. 9388134 - Compounds containing S-N-valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations (2016-07-12),
7. 9365565 - Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereof (2016-06-14),
8. 9309229 - Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine (2016-04-12),
9. 9273026 - Carbamate/urea derivatives (2016-03-01),
10. 9181215 - Manufacturing process for pyrimidine derivatives (2015-11-10),
11. 9163005 - Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide (2015-10-20),
12. 9034874 - Carbamate/urea derivatives (2015-05-19),
13. 8877938 - Compounds containing S-N-valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations (2014-11-04),
14. 8865897 - [object Object] (2014-10-21),
15. 8697682 - Salts (2014-04-15),

Title: Piotr Henryk Karpinski: A Visionary in the Field of Inventions

Introduction:

Piotr Henryk Karpinski, a prolific inventor based in Lincoln Park, NJ (US), has made a significant impact in the world of technology with his relentless pursuit of innovation and dedication to pushing boundaries. With 23 patents to his name, Karpinski continues to inspire the next generation of inventors and innovators with his groundbreaking work.

Latest Patents:

Among his latest patents is an amorphous solid form of compounds containing S--N-valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations. This compound is designed for the treatment of hypertension and/or heart failure, showcasing Karpinski's commitment to developing innovative solutions in the medical field.

Career Highlights:

Karpinski's notable career includes contributions to renowned companies such as Novartis AG and Novartis Pharmaceuticals Corporation. His expertise and inventive spirit have been instrumental in advancing pharmaceutical technologies, benefiting countless individuals worldwide.

Collaborations:

Throughout his career, Karpinski has collaborated with esteemed professionals such as Paul Allen Sutton and Mahavir Prashad. These partnerships have led to the development of pioneering inventions that have had a lasting impact on the industry.

Conclusion:

In conclusion, Piotr Henryk Karpinski stands as a true visionary in the field of inventions, with a track record of innovation and groundbreaking patents that have shaped the technological landscape. His dedication to pushing the boundaries of technology and commitment to creating solutions for critical medical issues make him a driving force in the world of inventions. Karpinski's legacy will undoubtedly continue to inspire and drive progress in the field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…